Pharmaceuticals, Biotechnology and Life Sciences
Announced Positive Efficacy Data from Animal Studies of COVID-19 Vaccine Candidate, TNX-1800 Interim Analysis of Second Confirmatory Phase 3 Study…
Lille, France; Cambridge, MA; May 10, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving…
– PLN-74809 Phase 2a PET Imaging Trial Continues to Enroll with Preliminary Data Expected First Half of 2021 – PLN-74809…
Collaboration aims to identify novel AAV capsids with enhanced properties to facilitate the development of new gene therapies for CNS…
Successful $276 Million IPO Completed to Advance GeneTACTM Programs for Friedreich Ataxia and Myotonic Dystrophy Type-1 Toward Clinical Development Company…
Advancement of Aligos’ drug candidates continues to be on trackSOUTH SAN FRANCISCO, Calif., May 10, 2021 (GLOBE NEWSWIRE) — Aligos…
CANTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on…
CAMBRIDGE, Mass., May 10, 2021 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to…
MELBOURNE, Australia, May 09, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has…
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH…